{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:35:55Z","timestamp":1792683355334,"version":"4.5.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Emerg Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intra-abdominal infections (IAIs) are an important cause of morbidity and mortality in hospital settings worldwide. The cornerstones of IAI management include rapid, accurate diagnostics; timely, adequate source control; appropriate, short-duration antimicrobial therapy administered according to the principles of pharmacokinetics\/pharmacodynamics and antimicrobial stewardship; and hemodynamic and organ functional support with intravenous fluid and adjunctive vasopressor agents for critical illness (sepsis\/organ dysfunction or septic shock after correction of hypovolemia). In patients with IAIs, a personalized approach is crucial to optimize outcomes and should be based on multiple aspects that require careful clinical assessment. The anatomic extent of infection, the presumed pathogens involved and risk factors for antimicrobial resistance, the origin and extent of the infection, the patient\u2019s clinical condition, and the host\u2019s immune status should be assessed continuously to optimize the management of patients with complicated IAIs.<\/jats:p>","DOI":"10.1186\/s13017-024-00552-9","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:01:50Z","timestamp":1717826510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Intra-abdominal infections survival guide: a position statement by the Global Alliance For Infections In Surgery"],"prefix":"10.1186","volume":"19","author":[{"given":"Massimo","family":"Sartelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Barie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanni","family":"Agnoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majdi N.","family":"Al-Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ansaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Biffl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Buonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Cheadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese M.","family":"Duane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fugazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Giamarellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Labricciosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald V.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Marwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Maves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mingoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Montravers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Podda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sganga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipendra","family":"Thapaliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Tolonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ulrych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Vallicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Coccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"key":"552_CR1","doi-asserted-by":"publisher","first-page":"935343","DOI":"10.3389\/fmed.2022.935343","volume":"9","author":"R Meng","year":"2022","unstructured":"Meng R, Guan X, Sun L, Fei Z, Li Y, Luo M, et al. The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: a bayesian network meta-analysis. Front Med (Lausanne). 2022;9:935343.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"552_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1089\/sur.2018.009","volume":"19","author":"PS Barie","year":"2018","unstructured":"Barie PS. Outcomes of surgical sepsis. Surg Infect (Larchmt). 2018;19(2):230\u20135.","journal-title":"Surg Infect (Larchmt)"},{"key":"552_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13017-015-0055-0","volume":"10","author":"M Sartelli","year":"2015","unstructured":"Sartelli M, Abu-Zidan FM, Catena F, Griffiths EA, Di Saverio S, Coimbra R, et al. Global validation of the WSES Sepsis Severity score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study). World J Emerg Surg. 2015;10:61.","journal-title":"World J Emerg Surg"},{"issue":"1","key":"552_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13017-021-00387-8","volume":"16","author":"M Sartelli","year":"2021","unstructured":"Sartelli M, Coccolini F, Kluger Y, Agastra E, Abu-Zidan FM, Abbas AES, WSES\/GAIS\/SIS-, et al. E\/WSIS\/AAST global clinical pathways for patients with intra-abdominal infections. World J Emerg Surg. 2021;16(1):49.","journal-title":"World J Emerg Surg"},{"key":"552_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13017-017-0141-6","volume":"12","author":"M Sartelli","year":"2017","unstructured":"Sartelli M, Chichom-Mefire A, Labricciosa FM, Hardcastle T, Abu-Zidan FM, Adesunkanmi AK, et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017;12:29.","journal-title":"World J Emerg Surg"},{"issue":"10000","key":"552_CR6","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S0140-6736(15)00275-5","volume":"386","author":"A Bhangu","year":"2015","unstructured":"Bhangu A, S\u00f8reide K, Di Saverio S, Assarsson JH, Drake FT. Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management. Lancet. 2015;386(10000):1278\u201387.","journal-title":"Lancet"},{"issue":"10","key":"552_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/jama.2022.2350","volume":"327","author":"JR Gallaher","year":"2022","unstructured":"Gallaher JR, Charles A. Acute cholecystitis: a review. JAMA. 2022;327(10):965\u201375.","journal-title":"JAMA"},{"key":"552_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-7922-1-13","volume":"26","author":"S Gupta","year":"2006","unstructured":"Gupta S, Kaushik R. Peritonitis-the eastern experience. World J Emerg Surg. 2006;26:13.","journal-title":"World J Emerg Surg"},{"issue":"1","key":"552_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13017-023-00509-4","volume":"18","author":"F Coccolini","year":"2023","unstructured":"Coccolini F, Sartelli M, Sawyer R, Rasa K, Viaggi B, Abu-Zidan F, et al. Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines. World J Emerg Surg. 2023;18(1):41.","journal-title":"World J Emerg Surg"},{"key":"552_CR10","doi-asserted-by":"crossref","unstructured":"Coccolini F, Sartelli M, Kirkpatrick AW. What do we mean by source control and what are we trying to accomplish with an open abdomen in severe complicated intra-abdominal sepsis? J Trauma Acute Care Surg. 2024 Jan 10.","DOI":"10.1097\/TA.0000000000004253"},{"issue":"1","key":"552_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/000313481107700126","volume":"77","author":"CB Moore","year":"2011","unstructured":"Moore CB, Smith RS, Herbertson R, Toevs C. Does use of intraoperative irrigation with open or laparoscopic appendectomy reduce post-operative intra-abdominal abscess? Am Surg. 2011;77(1):78\u201380.","journal-title":"Am Surg"},{"issue":"4","key":"552_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/SLA.0b013e31826a91e5","volume":"256","author":"SD St Peter","year":"2012","unstructured":"St Peter SD, Adibe OO, Iqbal CW, Fike FB, Sharp SW, Juang D, et al. Irrigation versus suction alone during laparoscopic appendectomy for perforated appendicitis: a prospective randomized trial. Ann Surg. 2012;256(4):581\u20135.","journal-title":"Ann Surg"},{"issue":"2","key":"552_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jss.2012.04.043","volume":"180","author":"JE Hartwich","year":"2013","unstructured":"Hartwich JE, Carter RF, Wolfe L, Goretsky M, Heath K, St Peter SD, Lanning DA. The effects of irrigation on outcomes in cases of perforated appendicitis in children. J Surg Res. 2013;180(2):222\u20135.","journal-title":"J Surg Res"},{"issue":"4","key":"552_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jvir.2019.12.001","volume":"31","author":"SR Dariushnia","year":"2020","unstructured":"Dariushnia SR, Mitchell JW, Chaudry G, Hogan MJ. Society of Interventional Radiology quality improvement standards for image-guided percutaneous drainage and aspiration of abscesses and fluid collections. J Vasc Interv Radiol. 2020;31(4):662\u2013e6664.","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"552_CR15","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1515\/cclm-2018-1181","volume":"57","author":"P Schuetz","year":"2019","unstructured":"Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international expert consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308\u201318.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"552_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206\u201317.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"552_CR17","first-page":"CD009977","volume":"2019","author":"B Rud","year":"2019","unstructured":"Rud B, Vejborg TS, Rappeport ED, Reitsma JB, Wille-J\u00f8rgensen P. Computed tomography for diagnosis of acute appendicitis in adults. Cochrane Database Syst Rev. 2019;2019(11):CD009977.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"552_CR18","doi-asserted-by":"publisher","first-page":"e231112","DOI":"10.1001\/jamasurg.2023.1112","volume":"158","author":"H Shaish","year":"2023","unstructured":"Shaish H, Ream J, Huang C, Troost J, Gaur S, Chung R, et al. Diagnostic accuracy of Unenhanced computed tomography for evaluation of Acute Abdominal Pain in the Emergency Department. JAMA Surg. 2023;158(7):e231112.","journal-title":"JAMA Surg"},{"issue":"2","key":"552_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s00261-023-04059-w","volume":"49","author":"DD Childs","year":"2024","unstructured":"Childs DD, Lalwani N, Craven T, Arif H, Morgan M, Anderson M, Fulcher A. A meta-analysis of the performance of ultrasound, hepatobiliary scintigraphy, CT and MRI in the diagnosis of acute cholecystitis. Abdom Radiol (NY). 2024;49(2):384\u201398.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"552_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.radi.2022.08.012","volume":"28","author":"E Arruzza","year":"2022","unstructured":"Arruzza E, Milanese S, Li LSK, Dizon J. Diagnostic accuracy of computed tomography and ultrasound for the diagnosis of acute appendicitis: a systematic review and meta-analysis. Radiography (Lond). 2022;28(4):1127\u201341.","journal-title":"Radiography (Lond)"},{"issue":"9","key":"552_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2022.2761","volume":"157","author":"KM Reitz","year":"2022","unstructured":"Reitz KM, Kennedy J, Li SR, Handzel R, Tonetti DA, Neal MD, et al. Association between time to source control in sepsis and 90-day mortality. JAMA Surg. 2022;157(9):817\u201326.","journal-title":"JAMA Surg"},{"issue":"7","key":"552_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3109\/00365521.2014.908475","volume":"49","author":"CS Andeweg","year":"2014","unstructured":"Andeweg CS, Wegdam JA, Groenewoud J, van der Wilt GJ, van Goor H, Bleichrodt RP. Toward an evidence-based step-up approach in diagnosing diverticulitis. Scand J Gastroenterol. 2014;49(7):775\u201384.","journal-title":"Scand J Gastroenterol"},{"key":"552_CR23","doi-asserted-by":"publisher","first-page":"b2431","DOI":"10.1136\/bmj.b2431","volume":"338","author":"W Lam\u00e9ris","year":"2009","unstructured":"Lam\u00e9ris W, van Randen A, van Es HW, van Heesewijk JP, van Ramshorst B, Bouma WH, et al. Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study. BMJ. 2009;338:b2431.","journal-title":"BMJ"},{"issue":"4","key":"552_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.rcl.2019.02.010","volume":"57","author":"JW Uyeda","year":"2019","unstructured":"Uyeda JW. Utility of MR imaging in abdominopelvic emergencies. Radiol Clin North Am. 2019;57(4):705\u201315.","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"552_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13244-019-0823-6","volume":"11","author":"S Pouli","year":"2020","unstructured":"Pouli S, Kozana A, Papakitsou I, Daskalogiannaki M, Raissaki M. Gastrointestinal perforation: clinical and MDCT clues for identification of aetiology. Insights Imaging. 2020;11(1):31.","journal-title":"Insights Imaging"},{"issue":"1","key":"552_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1749-7922-9-22","volume":"9","author":"M Sartelli","year":"2014","unstructured":"Sartelli M, Catena F, Di Saverio S, Ansaloni L, Malangoni M, Moore EE, et al. Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg. 2014;9(1):22.","journal-title":"World J Emerg Surg"},{"key":"552_CR27","first-page":"CD001439","volume":"3","author":"BR Andersen","year":"2005","unstructured":"Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005;3:CD001439.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"552_CR28","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s00268-012-1572-6","volume":"36","author":"H Mazeh","year":"2012","unstructured":"Mazeh H, Mizrahi I, Dior U, Simanovsky N, Shapiro M, Freund HR, Eid A. Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial. World J Surg. 2012;36(8):1750\u20139.","journal-title":"World J Surg"},{"issue":"2","key":"552_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jama.2014.7586","volume":"312","author":"JM Regimbeau","year":"2014","unstructured":"Regimbeau JM, Fuks D, Pautrat K, Mauvais F, Haccart V, Msika S, et al. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA. 2014;312(2):145\u201354.","journal-title":"JAMA"},{"issue":"9","key":"552_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1001\/jamasurg.2022.2937","volume":"157","author":"RM de Almeida Leite","year":"2022","unstructured":"de Almeida Leite RM, Seo DJ, Gomez-Eslava B, Hossain S, Lesegretain A, de Souza AV, et al. Nonoperative vs Operative Management of uncomplicated Acute appendicitis: a systematic review and Meta-analysis. JAMA Surg. 2022;157(9):828\u201334.","journal-title":"JAMA Surg"},{"issue":"6","key":"552_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/bjs.10147","volume":"103","author":"V Sallinen","year":"2016","unstructured":"Sallinen V, Akl EA, You JJ, Agarwal A, Shoucair S, Vandvik PO, et al. Meta-analysis of antibiotics versus appendicectomy for non-perforated acute appendicitis. Br J Surg. 2016;103(6):656\u201367.","journal-title":"Br J Surg"},{"issue":"23","key":"552_CR32","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1001\/jama.2015.6154","volume":"313","author":"P Salminen","year":"2015","unstructured":"Salminen P, Paajanen H, Rautio T, Nordstr\u00f6m P, Aarnio M, Rantanen T, et al. Antibiotic therapy vs appendectomy for treatment of uncomplicated Acute appendicitis: the APPAC Randomized Clinical Trial. JAMA. 2015;313(23):2340\u20138.","journal-title":"JAMA"},{"issue":"6","key":"552_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/TA.0000000000003581","volume":"92","author":"DD Yeh","year":"2022","unstructured":"Yeh DD, Vasileiou G, Qian S, Zhang H, Abdul Jawad K, Dodgion C, et al. Appendectomy versus nonoperative management of simple appendicitis: a post hoc analysis of an Eastern Association for the surgery of Trauma multicenter study using a hierarchical ordinal scale. J Trauma Acute Care Surg. 2022;92(6):1031\u20138.","journal-title":"J Trauma Acute Care Surg"},{"issue":"12","key":"552_CR34","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1007\/s00464-018-6400-0","volume":"32","author":"Y Lyu","year":"2018","unstructured":"Lyu Y, Cheng Y, Wang B, Zhao S, Chen L. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: an up-to-date meta-analysis of randomized controlled trials. Surg Endosc. 2018;32(12):4728\u201341.","journal-title":"Surg Endosc"},{"issue":"4","key":"552_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/bjs.8688","volume":"99","author":"A Chabok","year":"2012","unstructured":"Chabok A, P\u00e5hlman L, Hjern F, Haapaniemi S, Smedh K, AVOD Study Group. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg. 2012;99(4):532\u20139.","journal-title":"Br J Surg"},{"key":"552_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/DCR.0000000000000579","volume":"59","author":"JP Mali","year":"2016","unstructured":"Mali JP, Mentula PJ, Lepp\u00e4niemi AK, Sallinen VJ. Symptomatic treatment for uncomplicated acute diverticulitis: a prospective cohort study. Dis Colon Rectum. 2016;59:529\u201334.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"552_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/bjs.10309","volume":"104","author":"L Daniels","year":"2017","unstructured":"Daniels L, \u00dcnl\u00fc \u00c7, de Korte N, van Dieren S, Stockmann HB, Vrouenraets BC, et al. Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis. Br J Surg. 2017;104(1):52\u201361.","journal-title":"Br J Surg"},{"issue":"2","key":"552_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/sur.2022.363","volume":"24","author":"PS Barie","year":"2023","unstructured":"Barie PS, Kao LS, Moody M, Sawyer RG. Infection or inflammation: are uncomplicated acute appendicitis, acute cholecystitis, and acute diverticulitis infectious diseases? Surg Infect (Larchmt). 2023;24(2):99\u2013111.","journal-title":"Surg Infect (Larchmt)"},{"issue":"7","key":"552_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41395-018-0030-y","volume":"113","author":"ST van Dijk","year":"2018","unstructured":"van Dijk ST, Daniels L, \u00dcnl\u00fc \u00c7, de Korte N, van Dieren S, Stockmann HB, et al. Long-Term effects of omitting antibiotics in uncomplicated Acute Diverticulitis. Am J Gastroenterol. 2018;113(7):1045\u201352.","journal-title":"Am J Gastroenterol"},{"key":"552_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13017-016-0095-0","volume":"11","author":"M Sartelli","year":"2016","unstructured":"Sartelli M, Weber DG, Kluger Y, Ansaloni L, Coccolini F, Abu-Zidan F, et al. WSES guidelines for the management of acute left sided colonic diverticulitis in the emergency setting. World J Emerg Surg. 2016;11:37.","journal-title":"World J Emerg Surg"},{"issue":"6","key":"552_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/DCR.0b013e31820ef759","volume":"54","author":"S Dharmarajan","year":"2011","unstructured":"Dharmarajan S, Hunt SR, Birnbaum EH, Fleshman JW, Mutch MG. The efficacy of nonoperative management of acute complicated diverticulitis. Dis Colon Rectum. 2011;54(6):663\u201371.","journal-title":"Dis Colon Rectum"},{"key":"552_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/DCR.0000000000000083","volume":"57","author":"VJ Sallinen","year":"2014","unstructured":"Sallinen VJ, Mentula PJ, Lepp\u00e4niemi AK. Nonoperative management of perforated diverticulitis with extraluminal air is safe and effective in selected patients. Dis Colon Rectum. 2014;57:875\u201381.","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"552_CR43","first-page":"e12045","volume":"12","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Feroz SH, Dominic JL, Muralidharan A, Thirunavukarasu P. Is emergency appendicectomy better than elective appendicectomy for the treatment of appendiceal phlegmon? A review. Cureus. 2020;12(12):e12045.","journal-title":"Cureus"},{"issue":"4","key":"552_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/TA.0000000000003998","volume":"95","author":"JH Ra","year":"2023","unstructured":"Ra JH, Rattan R, Patel NJ, Bhattacharya B, Butts CA, Gupta S, et al. Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: a systematic review, meta-analysis, and practice management guideline from the Eastern Association for the surgery of Trauma. J Trauma Acute Care Surg. 2023;95(4):603\u201312.","journal-title":"J Trauma Acute Care Surg"},{"issue":"21","key":"552_CR45","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","volume":"372","author":"RG Sawyer","year":"2015","unstructured":"Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372(21):1996\u20132005.","journal-title":"N Engl J Med"},{"issue":"6","key":"552_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/sur.2017.084","volume":"18","author":"TE Hassinger","year":"2017","unstructured":"Hassinger TE, Guidry CA, Rotstein OD, Duane TM, Evans HL, Cook CH, et al. Longer-duration antimicrobial therapy does not prevent treatment failure in high-risk patients with complicated intra-abdominal infections. Surg Infect (Larchmt). 2017;18(6):659\u201363.","journal-title":"Surg Infect (Larchmt)"},{"issue":"10374","key":"552_CR47","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0140-6736(22)02588-0","volume":"401","author":"EML de Wijkerslooth","year":"2023","unstructured":"de Wijkerslooth EML, Boerma EG, van Rossem CC, van Rosmalen J, Baeten CIM, Beverdam FH, et al. 2 days versus 5 days of postoperative antibiotics for complex appendicitis: a pragmatic, open-label, multicentre, non-inferiority randomised trial. Lancet. 2023;401(10374):366\u201376.","journal-title":"Lancet"},{"issue":"3","key":"552_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00134-018-5088-x","volume":"44","author":"P Montravers","year":"2018","unstructured":"Montravers P, Tubach F, Lescot T, Veber B, Esposito-Far\u00e8se M, Seguin P, DURAPOP Trial Group, et al. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med. 2018;44(3):300\u201310.","journal-title":"Intensive Care Med"},{"key":"552_CR49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008;177:498\u2013505.","journal-title":"Am J Respir Crit Care Med"},{"key":"552_CR50","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, Nobre V. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med. 2013;41:2336\u201343.","journal-title":"Crit Care Med"},{"issue":"4","key":"552_CR51","first-page":"382","volume":"33","author":"R Qu","year":"2012","unstructured":"Qu R, Ji Y, Ling Y, Ye CY, Yang SM, Liu YY, et al. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial. Saudi Med J. 2012;33(4):382\u20137.","journal-title":"Saudi Med J"},{"issue":"2","key":"552_CR52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00423-008-0432-1","volume":"394","author":"S Schroeder","year":"2009","unstructured":"Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009;394(2):221\u20136.","journal-title":"Langenbecks Arch Surg"},{"key":"552_CR53","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1164\/rccm.201408-1483OC","volume":"190","author":"Y Shehabi","year":"2014","unstructured":"Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med. 2014;190:1102\u201310.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"552_CR54","doi-asserted-by":"publisher","first-page":"e90539","DOI":"10.1371\/journal.pone.0090539","volume":"9","author":"TS Huang","year":"2014","unstructured":"Huang TS, Huang SS, Shyu YC, Lee CH, Jwo SC, Chen PJ, Chen HY. A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis. PLoS ONE. 2014;9(3):e90539.","journal-title":"PLoS ONE"},{"key":"552_CR55","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jcrc.2014.12.014","volume":"30","author":"E Maseda","year":"2015","unstructured":"Maseda E, Suarez-de-la-Rica A, Anillo V, Tamayo E, Garc\u00eda-Bernedo CA, Ramasco F, et al. Procalcitonin-guided therapy may reduce length of AB treatment in intensive care unit patients with secondary peritonitis: a multicenter retrospective study. J Crit Care. 2015;30:537\u201342.","journal-title":"J Crit Care"},{"key":"552_CR56","doi-asserted-by":"publisher","first-page":"3457614","DOI":"10.1155\/2017\/3457614","volume":"2017","author":"JC Slieker","year":"2017","unstructured":"Slieker JC, Aellen S, Eggimann P, Guarnero V, Sch\u00e4fer M, Demartines N. Procalcitonin-guided antibiotics after surgery for Peritonitis: a randomized controlled study. Gastroenterol Res Pract. 2017;2017:3457614.","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"552_CR57","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.2165\/11599800-000000000-00000","volume":"72","author":"S Blot","year":"2012","unstructured":"Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs. 2012;72(6):e17\u201332.","journal-title":"Drugs"},{"issue":"1","key":"552_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13017-023-00528-1","volume":"18","author":"P Montravers","year":"2023","unstructured":"Montravers P, Grall N, Kantor E, Augustin P, Boussion K, Zappella N. Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999\u20132019. World J Emerg Surg. 2023;18(1):58.","journal-title":"World J Emerg Surg"},{"issue":"10","key":"552_CR59","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/antibiotics11101394","volume":"11","author":"M Sartelli","year":"2022","unstructured":"Sartelli M, Cristini F, Coccolini F, Labricciosa FM, Siquini W, Catena F. A proposal for a classification guiding the selection of Appropriate Antibiotic Therapy for Intra-abdominal infections. Antibiot (Basel). 2022;11(10):1394.","journal-title":"Antibiot (Basel)"},{"issue":"12","key":"552_CR60","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00134-019-05819-3","volume":"45","author":"S Blot","year":"2019","unstructured":"Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: AbSeS, a multinational observational cohort study and ESICM trials Group Project. Intensive Care Med. 2019;45(12):1703\u201317.","journal-title":"Intensive Care Med"},{"issue":"3","key":"552_CR61","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pan-drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"552_CR62","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1469-0691.12747","volume":"20","author":"M Giannella","year":"2014","unstructured":"Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20(12):1357\u201362.","journal-title":"Clin Microbiol Infect"},{"key":"552_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13017-016-0089-y","volume":"11","author":"M Sartelli","year":"2016","unstructured":"Sartelli M, Weber DG, Rupp\u00e9 E, Bassetti M, Wright BJ, Ansaloni L, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016;11:33.","journal-title":"World J Emerg Surg"},{"key":"552_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13756-017-0259-z","volume":"6","author":"AP Magiorakos","year":"2017","unstructured":"Magiorakos AP, Burns K, Rodr\u00edguez Ba\u00f1o J, Borg M, Daikos G, Dumpis U, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: Guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control. 2017;6:113.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"11","key":"552_CR65","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/ph6111335","volume":"6","author":"I Morrissey","year":"2013","unstructured":"Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D. A review of ten years of the study for Monitoring Antimicrobial Resistance trends (SMART) from 2002 to 2011. Pharmaceuticals (Basel). 2013;6(11):1335\u201346.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"552_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/AAC.03935-14","volume":"59","author":"SE Cain","year":"2015","unstructured":"Cain SE, Kohn J, Bookstaver PB, Albrecht H, Al-Hasan MN. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015;59(1):245\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"552_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/antibiotics9020061","volume":"9","author":"I Karaiskos","year":"2020","unstructured":"Karaiskos I, Giamarellou H. Carbapenem-sparing strategies for ESBL producers: when and how. Antibiot (Basel). 2020;9:61.","journal-title":"Antibiot (Basel)"},{"key":"552_CR68","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2018.12163","volume":"320","author":"PNA Harris","year":"2018","unstructured":"Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, et al. Effect of piperacillin-tazobactam vs. meropenem on 30-day mortality for patients with E. Coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320:984\u201394.","journal-title":"JAMA"},{"issue":"2","key":"552_CR69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 Guidance on the treatment of extended-spectrum \u03b2-lactamase Producing enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;75(2):187\u2013212.","journal-title":"Clin Infect Dis"},{"key":"552_CR70","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2147\/IDR.S314241","volume":"14","author":"M Gatti","year":"2021","unstructured":"Gatti M, Viaggi B, Rossolini GM, Pea F, Viale P. An evidence-based Multidisciplinary Approach focused at creating algorithms for targeted therapy of BSIs, cUTIs, and cIAIs caused by enterobacterales in critically ill adult patients. Infect Drug Resist. 2021;14:2461\u201398.","journal-title":"Infect Drug Resist"},{"key":"552_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s15010-014-0691-4","volume":"43","author":"WR Heizmann","year":"2015","unstructured":"Heizmann WR, L\u00f6schmann PA, Eckmann C, von Eiff C, Bodmann KF, Petrik C. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria. Infection. 2015;43:37\u201343.","journal-title":"Infection"},{"key":"552_CR72","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijantimicag.2013.01.020","volume":"41","author":"PC McGovern","year":"2013","unstructured":"McGovern PC, Wible M, El-Tahtawy A, Biswas P, Meyer RD. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. Int J Antimicrob Agents. 2013;41:463\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"552_CR73","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40265-019-01067-3","volume":"79","author":"LJ Scott","year":"2019","unstructured":"Scott LJ, Eravacycline. A review in complicated intra-abdominal infections. Drugs. 2019;79:315\u201324.","journal-title":"Drugs"},{"issue":"3","key":"552_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamasurg.2016.4237","volume":"152","author":"J Solomkin","year":"2017","unstructured":"Solomkin J, Evans D, Slepavicius A, Lee P, Marsh A, Tsai L, et al. Assessing the efficacy and safety of Eravacycline vs Ertapenem in complicated intra-abdominal infections in the investigating gram-negative infections treated with eravacycline (IGNITE 1) trial: a Randomized Clinical Trial. JAMA Surg. 2017;152(3):224\u201332.","journal-title":"JAMA Surg"},{"issue":"6","key":"552_CR75","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/cid\/ciy1029","volume":"69","author":"JS Solomkin","year":"2019","unstructured":"Solomkin JS, Gardovskis J, Lawrence K, Montravers P, Sway A, Evans D, Tsai L. IGNITE4: results of a phase 3, Randomized, Multicenter, prospective trial of Eravacycline vs Meropenem in the treatment of complicated Intraabdominal infections. Clin Infect Dis. 2019;69(6):921\u20139.","journal-title":"Clin Infect Dis"},{"key":"552_CR76","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jgar.2021.10.020","volume":"29","author":"ALV Hobbs","year":"2022","unstructured":"Hobbs ALV, Gelfand MS, Cleveland KO, Saddler K, Sierra-Hoffman MA. A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals. J Glob Antimicrob Resist. 2022;29:430\u20133.","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"552_CR77","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/14787210.2017.1379897","volume":"15","author":"AF Shorr","year":"2017","unstructured":"Shorr AF, Pogue JM, Mohr JF. Intravenous fosfomycin for the treatment of hospitalized patients with serious infections. Expert Rev Anti Infect Ther. 2017;15(10):935\u201345.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"552_CR78","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/civ097","volume":"60","author":"J Solomkin","year":"2015","unstructured":"Solomkin J, Hershberger E, Miller B, Popejoy M, Friedland I, Steenbergen J, et al. Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin Infect Dis. 2015;60:1462\u201371.","journal-title":"Clin Infect Dis"},{"key":"552_CR79","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/cid\/ciw133","volume":"62","author":"JE Mazuski","year":"2016","unstructured":"Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, et al. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program. Clin Infect Dis. 2016;62:1380\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"552_CR80","first-page":"519","volume":"11","author":"R Giurazza","year":"2021","unstructured":"Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging treatment options for multi-drug-resistant bacterial infections. Life (Basel). 2021;11(6):519.","journal-title":"Life (Basel)"},{"issue":"9","key":"552_CR81","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/cid\/ciz530","volume":"70","author":"J Motsch","year":"2020","unstructured":"Motsch J, Murta de Oliveira C, Stus V, K\u00f6ksal I, Lyulko O, Boucher HW, et al. RESTORE-IMI 1: a Multicenter, Randomized, double-blind trial comparing efficacy and Safety of Imipenem\/Relebactam vs Colistin Plus Imipenem in patients with Imipenem-nonsusceptible bacterial infections. Clin Infect Dis. 2020;70(9):1799\u2013808.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"552_CR82","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/1469-0691.12697","volume":"20","author":"LS Tzouvelekis","year":"2014","unstructured":"Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20(9):862\u201372.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"552_CR83","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/mdr.2019.0298","volume":"26","author":"A Iregui","year":"2020","unstructured":"Iregui A, Khan Z, Landman D, Quale J. Activity of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii endemic to medical centers in New York City. Microb Drug Resist. 2020;26(7):722\u20136.","journal-title":"Microb Drug Resist"},{"issue":"8","key":"552_CR84","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/sur.2017.121","volume":"18","author":"JM Sanders","year":"2017","unstructured":"Sanders JM, Tessier JM, Sawyer R, Dellinger EP, Miller PR, Namias N, et al. Does isolation of Enterococcus affect outcomes in intra-abdominal infections? Surg Infect (Larchmt). 2017;18(8):879\u201385.","journal-title":"Surg Infect (Larchmt)"},{"issue":"10","key":"552_CR85","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/jac\/dkr308","volume":"66","author":"H Dupont","year":"2011","unstructured":"Dupont H, Friggeri A, Touzeau J, Airapetian N, Tinturier F, Lobjoie E, et al. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother. 2011;66(10):2379\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"552_CR86","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-019-2581-8","volume":"23","author":"AC Morvan","year":"2019","unstructured":"Morvan AC, Hengy B, Garrouste-Orgeas M, Ruckly S, Forel JM, Argaud L, et al. Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-An analysis of the OUTCOMEREA database. Crit Care. 2019;23(1):307.","journal-title":"Crit Care"},{"issue":"2","key":"552_CR87","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/sur.2020.001","volume":"22","author":"J Zhang","year":"2021","unstructured":"Zhang J, Yu WQ, Chen W, Wei T, Wang CW, Zhang JY, et al. Systematic review and Meta-analysis of the efficacy of appropriate empiric anti-enterococcal therapy for intra-abdominal infection. Surg Infect (Larchmt). 2021;22(2):131\u201343.","journal-title":"Surg Infect (Larchmt)"},{"issue":"1","key":"552_CR88","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00384-023-04566-8","volume":"38","author":"BL Bancke Laverde","year":"2023","unstructured":"Bancke Laverde BL, Maak M, Langheinrich M, Kersting S, Denz A, Krautz C, et al. The role of intraoperative swab during appendectomy in patients with uncomplicated and complicated appendicitis. Int J Colorectal Dis. 2023;38(1):272.","journal-title":"Int J Colorectal Dis"},{"key":"552_CR89","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijsu.2010.06.016","volume":"8","author":"HO Davies","year":"2010","unstructured":"Davies HO, Alkhamesi NA, Dawson PM. Peritoneal fluid culture in appendicitis: review in changing times. Int J Surg. 2010;8:426\u20139.","journal-title":"Int J Surg"},{"issue":"6","key":"552_CR90","doi-asserted-by":"publisher","first-page":"106184","DOI":"10.1016\/j.ijantimicag.2020.106184","volume":"56","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Rello J, Blasi F, Goossens H, Sotgiu G, Tavoschi L, et al. Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections. Int J Antimicrob Agents. 2020;56(6):106184.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"552_CR91","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s40121-021-00585-6","volume":"11","author":"M Bassetti","year":"2022","unstructured":"Bassetti M, Vena A, Giacobbe DR, Trucchi C, Ansaldi F, Antonelli M, et al. Risk factors for intra-abdominal candidiasis in intensive care units: results from EUCANDICU study. Infect Dis Ther. 2022;11(2):827\u201340.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"552_CR92","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10096-016-2775-9","volume":"36","author":"L Lagunes","year":"2017","unstructured":"Lagunes L, Rey-P\u00e9rez A, Mart\u00edn-G\u00f3mez MT, Vena A, de Egea V, Mu\u00f1oz P, et al. Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain. Eur J Clin Microbiol Infect Dis. 2017;36(1):95\u2013104.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"552_CR93","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","volume":"34","author":"C Le\u00f3n","year":"2006","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (Candida score) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730\u20137.","journal-title":"Crit Care Med"},{"issue":"6","key":"552_CR94","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","volume":"45","author":"I Martin-Loeches","year":"2019","unstructured":"Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, et al. ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789\u2013805.","journal-title":"Intensive Care Med"},{"key":"552_CR95","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"552_CR96","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1128\/AAC.04134-14","volume":"58","author":"RK Shields","year":"2014","unstructured":"Shields RK, Nguyen MH, Press EG, Clancy CJ. Abdominal candidiasis is a hidden reservoir of echinocandin resistance. Antimicrob Agents Chemother. 2014;58(12):7601\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"552_CR97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijid.2020.09.019","volume":"101","author":"F Gioia","year":"2020","unstructured":"Gioia F, Gomez-Lopez A, Alvarez ME, de la Gomez-Garc\u00eda E, Mart\u00edn-Davila P, Cuenca-Estrella M, et al. Pharmacokinetics of echinocandins in suspected candida Peritonitis: a potential risk for resistance. Int J Infect Dis. 2020;101:24\u20138.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"552_CR98","doi-asserted-by":"publisher","first-page":"e0256520","DOI":"10.1128\/AAC.02565-20","volume":"65","author":"R Welte","year":"2021","unstructured":"Welte R, Oberacher H, Gasperetti T, Pfisterer H, Griesmacher A, Santner T, et al. Pharmacokinetics and antifungal activity of echinocandins in ascites fluid of critically ill patients. Antimicrob Agents Chemother. 2021;65(7):e0256520.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"552_CR99","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/jof7050376","volume":"7","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Batres Baires G, Schmid RM, Wiessner JR, Ulrich J, Reichert M, et al. Penetration of isavuconazole in ascites fluid of critically ill patients. J Fungi (Basel). 2021;7(5):376.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"552_CR100","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s13054-023-04673-6","volume":"27","author":"E Maseda","year":"2023","unstructured":"Maseda E, Mart\u00edn-Loeches I, Zaragoza R, Pem\u00e1n J, Fort\u00fan J, Grau S, et al. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis. Crit Care. 2023;27(1):382.","journal-title":"Crit Care"},{"issue":"6","key":"552_CR101","doi-asserted-by":"publisher","first-page":"106998","DOI":"10.1016\/j.ijantimicag.2023.106998","volume":"62","author":"M Rinaldi","year":"2023","unstructured":"Rinaldi M, Bartoletti M, Bonazzetti C, Caroccia N, Gatti M, Tazza B, et al. Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: a phase 2 study (LAMBDA study). Int J Antimicrob Agents. 2023;62(6):106998.","journal-title":"Int J Antimicrob Agents"},{"key":"552_CR102","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (SEPSIS-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"issue":"3","key":"552_CR103","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/sur.2019.126","volume":"21","author":"VP Ho","year":"2020","unstructured":"Ho VP, Kaafarani H, Rattan R, Namias N, Evans H, Zakrison TL. Sepsis 2019: what surgeons need to know. Surg Infect (Larchmt). 2020;21(3):195\u2013204.","journal-title":"Surg Infect (Larchmt)"},{"key":"552_CR104","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.CCM.0000260960.94300.DE","volume":"35","author":"A Esteban","year":"2007","unstructured":"Esteban A, Frutos-Vivar F, Ferguson ND, Pe\u00f1uelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35:1284\u20139.","journal-title":"Crit Care Med"},{"key":"552_CR105","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19:e422\u201336.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"552_CR106","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143.","journal-title":"Crit Care Med"},{"key":"552_CR107","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378:829\u201339.","journal-title":"N Engl J Med"},{"key":"552_CR108","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1711586","volume":"378","author":"WH Self","year":"2018","unstructured":"Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, et al. Balanced crystalloids versus saline in noncritically ill adults. N Engl J Med. 2018;378:819\u201328.","journal-title":"N Engl J Med"},{"issue":"3","key":"552_CR109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1074248414559838","volume":"20","author":"JC Jentzer","year":"2015","unstructured":"Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit. J Cardiovasc Pharmacol Ther. 2015;20(3):249\u201360.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"Suppl 2","key":"552_CR110","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1093\/infdis\/jiaa146","volume":"222","author":"J Weinberger","year":"2020","unstructured":"Weinberger J, Rhee C, Klompas M. A critical analysis of the literature on time-to-antibiotics in suspected sepsis. J Infect Dis. 2020;222(Suppl 2):S110\u20138.","journal-title":"J Infect Dis"},{"issue":"1","key":"552_CR111","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13054-018-2144-4","volume":"22","author":"P Nandhabalan","year":"2018","unstructured":"Nandhabalan P, Ioannou N, Meadows C, Wyncoll D. Refractory septic shock: our pragmatic approach. Crit Care. 2018;22(1):215.","journal-title":"Crit Care"},{"issue":"5","key":"552_CR112","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509\u201318.","journal-title":"JAMA"},{"issue":"1","key":"552_CR113","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13613-018-0402-x","volume":"8","author":"MLNG Malbrain","year":"2018","unstructured":"Malbrain MLNG, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal PJ, Joannes-Boyau O, et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D\u2019s and the four phases of fluid therapy. Ann Intensive Care. 2018;8(1):66.","journal-title":"Ann Intensive Care"},{"issue":"15","key":"552_CR114","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","volume":"167","author":"JA Kellum","year":"2007","unstructured":"Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of Sepsis (GenIMS) study. Arch Intern Med. 2007;167(15):1655\u201363.","journal-title":"Arch Intern Med"},{"issue":"1","key":"552_CR115","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/315214","volume":"181","author":"CA Gogos","year":"2000","unstructured":"Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181(1):176\u201380.","journal-title":"J Infect Dis"},{"issue":"8","key":"552_CR116","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/039139881003300801","volume":"33","author":"Z Peng","year":"2010","unstructured":"Peng Z, Pai P, Han-Min W, Jun Z, Hong-Bao L, Rong L, Chen H. Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: a preliminary study. Int J Artif Organs. 2010;33(8):505\u201311.","journal-title":"Int J Artif Organs"},{"key":"552_CR117","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1097\/CCM.0b013e31828cf412","volume":"41","author":"F Zhou","year":"2013","unstructured":"Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41:2209\u201320.","journal-title":"Crit Care Med"},{"issue":"2","key":"552_CR118","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/cc5780","volume":"11","author":"DN Cruz","year":"2007","unstructured":"Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11(2):R47.","journal-title":"Crit Care"},{"issue":"23","key":"552_CR119","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301(23):2445\u201352.","journal-title":"JAMA"},{"issue":"6","key":"552_CR120","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975\u201384.","journal-title":"Intensive Care Med"},{"key":"552_CR121","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1745-6215-15-218","volume":"15","author":"DJ Klein","year":"2014","unstructured":"Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP. The EUPHRATES trial (evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of adults treated for endotoxemia and septic shock): study protocol for a randomized controlled trial. Trials. 2014;15:218.","journal-title":"Trials"},{"issue":"12","key":"552_CR122","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44(12):2205\u201312.","journal-title":"Intensive Care Med"},{"issue":"5","key":"552_CR123","first-page":"559","volume":"82","author":"S Busani","year":"2016","unstructured":"Busani S, Damiani E, Cavazzuti I, Donati A, Girardis M. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol. 2016;82(5):559\u201372.","journal-title":"Minerva Anestesiol"},{"issue":"12","key":"552_CR124","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1097\/CCM.0000000000000620","volume":"42","author":"A Kumar","year":"2014","unstructured":"Kumar A. Antimicrobial delay and outcome in severe sepsis. Crit Care Med. 2014;42(12):e802.","journal-title":"Crit Care Med"},{"issue":"10","key":"552_CR125","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","volume":"12","author":"T Hranjec","year":"2012","unstructured":"Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis. 2012;12(10):774\u201380.","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"552_CR126","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235\u201344.","journal-title":"N Engl J Med"},{"issue":"10","key":"552_CR127","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","volume":"44","author":"F Pea","year":"2005","unstructured":"Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet. 2005;44(10):1009\u201334.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"552_CR128","doi-asserted-by":"publisher","first-page":"e0201667","DOI":"10.1371\/journal.pone.0201667","volume":"13","author":"Z Yu","year":"2018","unstructured":"Yu Z, Pang X, Wu X, Shan C, Jiang S. Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: a meta-analysis. PLoS ONE. 2018;13(7):e0201667.","journal-title":"PLoS ONE"},{"issue":"2","key":"552_CR129","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/CCM.0000000000002836","volume":"46","author":"NJ Rhodes","year":"2018","unstructured":"Rhodes NJ, Liu J, O\u2019Donnell JN, Dulhunty JM, Abdul-Aziz MH, Berko PY, et al. Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis. Crit Care Med. 2018;46(2):236\u201343.","journal-title":"Crit Care Med"},{"issue":"1","key":"552_CR130","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","volume":"18","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME. Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis. 2018;18(1):108\u201320.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"552_CR131","doi-asserted-by":"publisher","first-page":"e0116769","DOI":"10.1371\/journal.pone.0116769","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang H, Zhang C, Zhou Q, Wang Y, Chen L. Clinical outcomes with alternative dosing strategies for piperacillin\/tazobactam: a systematic review and meta-analysis. PLoS ONE. 2015;10(1):e0116769.","journal-title":"PLoS ONE"},{"issue":"1","key":"552_CR132","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/jac\/dkz407","volume":"75","author":"L Leon","year":"2020","unstructured":"Leon L, Guerci P, Pape E, Thilly N, Luc A, Germain A, et al. Serum and peritoneal exudate concentrations after high doses of \u03b2-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study. J Antimicrob Chemother. 2020;75(1):156\u201361.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"552_CR133","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/jac\/dkad223","volume":"78","author":"R Pai Mangalore","year":"2023","unstructured":"Pai Mangalore R, Peel TN, Udy AA, Peleg AY. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting. J Antimicrob Chemother. 2023;78(10):2395\u2013405.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"552_CR134","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/cc13755","volume":"18","author":"F Bloos","year":"2014","unstructured":"Bloos F, Thomas-R\u00fcddel D, R\u00fcddel H, Engel C, Schwarzkopf D, Marshall JC, et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care. 2014;18(2):R42.","journal-title":"Crit Care"},{"issue":"11","key":"552_CR135","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","volume":"43","author":"F Bloos","year":"2017","unstructured":"Bloos F, R\u00fcddel H, Thomas-R\u00fcddel D, Schwarzkopf D, Pausch C, Harbarth S, et al. Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med. 2017;43(11):1602\u201312.","journal-title":"Intensive Care Med"},{"key":"552_CR136","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/cc13854","volume":"18","author":"T Azuhata","year":"2014","unstructured":"Azuhata T, Kinoshita K, Kawano D. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care. 2014;18:R87.","journal-title":"Crit Care"},{"issue":"11","key":"552_CR137","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00134-022-06883-y","volume":"48","author":"G De Pascale","year":"2022","unstructured":"De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown BC, et al. Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis. Intensive Care Med. 2022;48(11):1593\u2013606.","journal-title":"Intensive Care Med"},{"issue":"1","key":"552_CR138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13054-022-03901-9","volume":"26","author":"H R\u00fcddel","year":"2022","unstructured":"R\u00fcddel H, Thomas-R\u00fcddel DO, Reinhart K, Bach F, Gerlach H, Lindner M, et al. MEDUSA study group. Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial. Crit Care. 2022;26(1):51.","journal-title":"Crit Care"},{"issue":"6","key":"552_CR139","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/TA.0000000000003488","volume":"92","author":"T Haltmeier","year":"2022","unstructured":"Haltmeier T, Falke M, Quaile O, Candinas D, Schn\u00fcriger B. Damage-control surgery in patients with nontraumatic abdominal emergencies: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2022;92(6):1075\u201385.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"552_CR140","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1002\/bjs.9360","volume":"101","author":"DG Weber","year":"2014","unstructured":"Weber DG, Bendinelli C, Balogh ZJ. Damage control surgery for abdominal emergencies. Br J Surg. 2014;101(1):e109\u2013118.","journal-title":"Br J Surg"},{"key":"552_CR141","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13017-018-0183-4","volume":"13","author":"AW Kirkpatrick","year":"2018","unstructured":"Kirkpatrick AW, Coccolini F, Ansaloni L, Roberts DJ, Tolonen M, McKee JL, et al. Closed or open after source control laparotomy for severe complicated intra-abdominal sepsis (the COOL trial): study protocol for a randomized controlled trial. World J Emerg Surg. 2018;13:26.","journal-title":"World J Emerg Surg"},{"issue":"12","key":"552_CR142","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ijsu.2014.10.032","volume":"12","author":"T Samdani","year":"2014","unstructured":"Samdani T, Pieracci FM, Eachempati SR, Benarroch-Gampel J, Weiss A, Pietanza MC, et al. Colonic diverticulitis in chemotherapy patients: should operative indications change? A retrospective cohort study. Int J Surg. 2014;12(12):1489\u201394.","journal-title":"Int J Surg"},{"issue":"1","key":"552_CR143","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13017-021-00380-1","volume":"16","author":"F Coccolini","year":"2021","unstructured":"Coccolini F, Improta M, Sartelli M, Rasa K, Sawyer R, Coimbra R, et al. Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines. World J Emerg Surg. 2021;16(1):40.","journal-title":"World J Emerg Surg"},{"issue":"8","key":"552_CR144","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1007\/s00432-022-04367-6","volume":"149","author":"A Mathew","year":"2023","unstructured":"Mathew A, Shatila M, Lai Z. Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patients. J Cancer Res Clin Oncol. 2023;149(8):4591\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"552_CR145","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10151-023-02758-6","volume":"27","author":"D Tartaglia","year":"2023","unstructured":"Tartaglia D, Cremonini C, Annunziata E, Catena F, Sartelli M, Kirkpatrick AW, et al. Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (web-based International Register of Emergency Surgery and trauma, WIRES-T). Tech Coloproctol. 2023;27(9):747\u201357.","journal-title":"Tech Coloproctol"},{"key":"552_CR146","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/DCR.0b013e3181f5643c","volume":"53","author":"SS Hwang","year":"2010","unstructured":"Hwang SS, Cannom RR, Abbas MA, Etzioni D. Diverticulitis in transplant patients and patients on chronic corticosteroid therapy: a systematic review. Dis Colon Rectum. 2010;53:1699\u2013707.","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"552_CR147","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1007\/s11605-014-2593-2","volume":"18","author":"JE Oor","year":"2014","unstructured":"Oor JE, Atema JJ, Boermeester MA, Vrouenraets BC, \u00dcnl\u00fc \u00c7. A systematic review of complicated diverticulitis in post-transplant patients. J Gastrointest Surg. 2014;18(11):2038\u201346.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"552_CR148","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cmi.2022.06.005","volume":"29","author":"B Pilmis","year":"2023","unstructured":"Pilmis B, Weiss E, Scemla A, Le Monnier A, Grossi PA, Slavin MA, et al. Multidrug-resistant enterobacterales infections in abdominal solid organ transplantation. Clin Microbiol Infect. 2023;29(1):38\u201343.","journal-title":"Clin Microbiol Infect"}],"container-title":["World Journal of Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13017-024-00552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13017-024-00552-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13017-024-00552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T07:01:38Z","timestamp":1717830098000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjes.biomedcentral.com\/articles\/10.1186\/s13017-024-00552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":148,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1186\/s13017-024-00552-9","relation":{},"ISSN":["1749-7922"],"issn-type":[{"value":"1749-7922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.W.K. serves as the PI of the COOL trial, which previously was partially supported by the 3\u00a0M\/Acelity Corporation until Aug 2022. A.W.K. is also a member of the Canadian Forces Medical Services and has consulted for the 3\u00a0m\/Acelity Corporation, Zoll Medical, Innovative Trauma Care, and CSL Behring. A.W.K. is the Director of the TeleMentored Ultrasound Supported Medical Interventions (TMUSMI) Research group and serves in the Canadian Forces Medical Services.R.G.S conflicts are on Data Management and Safety Board for Advarra.R.C.M. received research support (paid to Institution) from AiCuris, GeoVax and Biotest. He received honoraria for participation in a scientific advisory board organized by Shionogi.All the other authors declare that they have no competing interests. R.G.S conflicts are on Data Management and Safety Board for Advarra. R.C.M. received research support (paid to Institution) from AiCuris, GeoVax and Biotest. He received honoraria for participation in a scientific advisory board organized by Shionogi. All the other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}